Article

Daily Medication Pearl: Vortioxetine (Trintellix)

Vortioxetine (Trintellix) treats major depressive disorder in adults.

Medication Pearl of the Day: Vortioxetine (Trintellix)

Indication: Trintellix is indicated for the treatment of major depressive disorder in adults.

Insight:

  • Dosing: The recommended starting dose is 10 mg administered orally once daily without regard to meals
  • Dosage forms: Tablets 5 mg, 10 mg, and 20 mg.
  • Adverse events: Most common adverse reactions (incidence ≥5% and at least twice the rate of placebo) were nausea, constipation, and vomiting.
  • Mechanism of action: The mechanism of the antidepressant effect of vortioxetine is not fully understood, but is thought to be related to its enhancement of serotonergic activity in the CNS through inhibition of the reuptake of serotonin.
  • Manufacturer: Takeda Pharma

Sources:

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit: Sebastian Kaulitzki | stock.adobe.com
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com